array:23 [ "pii" => "S1578219009701647" "issn" => "15782190" "doi" => "10.1016/S1578-2190(09)70164-7" "estado" => "S300" "fechaPublicacion" => "2009-10-01" "aid" => "70164" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "copyrightAnyo" => "2009" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2009;100:734-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2021 "formatos" => array:3 [ "EPUB" => 37 "HTML" => 1106 "PDF" => 878 ] ] "itemSiguiente" => array:18 [ "pii" => "S1578219009701659" "issn" => "15782190" "doi" => "10.1016/S1578-2190(09)70165-9" "estado" => "S300" "fechaPublicacion" => "2009-10-01" "aid" => "70165" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2009;100:736-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1884 "formatos" => array:3 [ "EPUB" => 29 "HTML" => 1069 "PDF" => 786 ] ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Science Letters</span>" "titulo" => "Palmoplantar Cutaneous Reaction to Sorafenib" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "736" "paginaFinal" => "737" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. Echeverría, B. Llombart, R. Botella-Estrada, C. Guillén" "autores" => array:4 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "Echeverría" ] 1 => array:2 [ "nombre" => "B." "apellidos" => "Llombart" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Botella-Estrada" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Guillén" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219009701659?idApp=UINPBA000044" "url" => "/15782190/0000010000000008/v1_201304241504/S1578219009701659/v1_201304241504/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1578219009701635" "issn" => "15782190" "doi" => "10.1016/S1578-2190(09)70163-5" "estado" => "S300" "fechaPublicacion" => "2009-10-01" "aid" => "70163" "copyright" => "Academia Española de Dermatología y Venereología and Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2009;100:732-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1915 "formatos" => array:3 [ "EPUB" => 32 "HTML" => 1117 "PDF" => 766 ] ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Science Letters</span>" "titulo" => "Patient With Malformations of the Face, Mouth, and Fingers: Type I Orofaciodigital or Papillon-Léage Psaume Syndrome" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "732" "paginaFinal" => "734" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Ciudad, F. Alfageme, P. Zamberk, R. Suárez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Ciudad" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Alfageme" ] 2 => array:2 [ "nombre" => "P." "apellidos" => "Zamberk" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Suárez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219009701635?idApp=UINPBA000044" "url" => "/15782190/0000010000000008/v1_201304241504/S1578219009701635/v1_201304241504/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical Science Letters</span>" "titulo" => "Refractory Subacute Cutaneous Lupus Erythematosus With a Response to Efalizumab" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "734" "paginaFinal" => "735" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "N. Guillermo, Y. Peñate, B. Hernández-Machín, L. Borrego" "autores" => array:4 [ 0 => array:4 [ "nombre" => "N." "apellidos" => "Guillermo" "email" => array:1 [ 0 => "noemiau21@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor1" ] ] ] 1 => array:2 [ "nombre" => "Y." "apellidos" => "Peñate" ] 2 => array:2 [ "nombre" => "B." "apellidos" => "Hernández-Machín" ] 3 => array:2 [ "nombre" => "L." "apellidos" => "Borrego" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "⁎" "correspondencia" => "Correspondence: Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Av. Marítima del Sur, s/n, 35016 Las Palmas de Gran Canaria, Spain." ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.I. Costner" 1 => "R.D. Sontheimer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Fitzpatrick's Dermatology in General Medicine" "paginaInicial" => "1677" "paginaFinal" => "1693" "edicion" => "6th ed." "serieFecha" => "2003" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Segunda parte: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab y cetuximab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Guhl" 1 => "B. Díaz-Ley" 2 => "J. Fernández-Herrera" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2008" "volumen" => "99" "paginaInicial" => "5" "paginaFinal" => "33" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18206084" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A single-center, open-label, prospective pilot study of subcutaneous efalizumab for oral erosive lichen planus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.P. Heffernan" 1 => "D.I. Smith" 2 => "D. Bentley" 3 => "M. Tabacchi" 4 => "J.E. Graves" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Drugs Dermatol" "fecha" => "2007" "volumen" => "6" "paginaInicial" => "310" "paginaFinal" => "314" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17373193" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T.H. Clayton" 1 => "S. Ogden" 2 => "M.D. Goodfield" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2005.08.025" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2006" "volumen" => "54" "paginaInicial" => "892" "paginaFinal" => "895" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16635677" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efalizumab in the treatment of discoid lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "N. Usmani" 1 => "M. Goodfield" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.143.7.873" "Revista" => array:7 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2007" "volumen" => "143" "paginaInicial" => "873" "paginaFinal" => "877" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17638731" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1552526010000166" "estado" => "S300" "issn" => "15525260" ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Hamprecht" 1 => "T. Tüting" 2 => "T. Bieber" 3 => "J. Wenzel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2230.2007.02684.x" "Revista" => array:7 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "2008" "volumen" => "33" "paginaInicial" => "347" "paginaFinal" => "348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18312454" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1552526011000227" "estado" => "S300" "issn" => "15525260" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efalizumab-induced subacute cutaneous lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D.D. Bentley" 1 => "J.E. Graves" 2 => "D.I. Smith" 3 => "M.P. Heffernan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2005.10.037" "Revista" => array:7 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2006" "volumen" => "54" "numero" => "5 Suppl" "paginaInicial" => "S242" "paginaFinal" => "S243" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16631956" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efalizumab-induced lupus-like syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Durox" 1 => "A. Sparsa" 2 => "V. Loustaud-Ratti" 3 => "S. Prey" 4 => "G. Gondran" 5 => "P. Manea" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2340/00015555-0393" "Revista" => array:6 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2008" "volumen" => "88" "paginaInicial" => "270" "paginaFinal" => "271" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18480928" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010000000008/v1_201304241504/S1578219009701647/v1_201304241504/en/main.assets" "Apartado" => array:4 [ "identificador" => "6242" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Clinical science letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010000000008/v1_201304241504/S1578219009701647/v1_201304241504/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219009701647?idApp=UINPBA000044" ]
Journal Information
Vol. 100. Issue 8.
Pages 734-735 (October 2009)
Vol. 100. Issue 8.
Pages 734-735 (October 2009)
Clinical Science Letters
Full text access
Refractory Subacute Cutaneous Lupus Erythematosus With a Response to Efalizumab
Visits
5091
N. Guillermo
, Y. Peñate, B. Hernández-Machín, L. Borrego
Corresponding author
noemiau21@hotmail.com
Correspondence: Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Av. Marítima del Sur, s/n, 35016 Las Palmas de Gran Canaria, Spain.
Correspondence: Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Av. Marítima del Sur, s/n, 35016 Las Palmas de Gran Canaria, Spain.
Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
M.I. Costner, R.D. Sontheimer.
Lupus erythematosus.
Fitzpatrick's Dermatology in General Medicine, 6th ed., pp. 1677-1693
[2.]
G. Guhl, B. Díaz-Ley, J. Fernández-Herrera.
Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Segunda parte: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab y cetuximab.
Actas Dermosifiliogr, 99 (2008), pp. 5-33
[3.]
M.P. Heffernan, D.I. Smith, D. Bentley, M. Tabacchi, J.E. Graves.
A single-center, open-label, prospective pilot study of subcutaneous efalizumab for oral erosive lichen planus.
J Drugs Dermatol, 6 (2007), pp. 310-314
[4.]
T.H. Clayton, S. Ogden, M.D. Goodfield.
Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab.
J Am Acad Dermatol, 54 (2006), pp. 892-895
[5.]
N. Usmani, M. Goodfield.
Efalizumab in the treatment of discoid lupus erythematosus.
Arch Dermatol, 143 (2007), pp. 873-877
[6.]
A. Hamprecht, T. Tüting, T. Bieber, J. Wenzel.
Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab.
Clin Exp Dermatol, 33 (2008), pp. 347-348
[7.]
D.D. Bentley, J.E. Graves, D.I. Smith, M.P. Heffernan.
Efalizumab-induced subacute cutaneous lupus erythematosus.
J Am Acad Dermatol, 54 (2006), pp. S242-S243
[8.]
H. Durox, A. Sparsa, V. Loustaud-Ratti, S. Prey, G. Gondran, P. Manea, et al.
Efalizumab-induced lupus-like syndrome.
Acta Derm Venereol, 88 (2008), pp. 270-271
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.